Connect with us

BenzingaEditorial

Healthcare – The Silver Lining of 2020

Published

on

Many of the best stocks in 2020 were healthcare companies focused on two disease areas: trying to stop the spread of COVID-19 and improving survival rates from deadly diseases. Their scientific achievements have been nothing less than extraordinary. By looking at healthcare companies with market caps above $200 million from the beginning of the year until December 1st, here are the top ten that delivered highest returns during the unprecedented pandemic that caused nothing less than an economic turmoil.

  1. Novavax

Novavax’s (NASDAQ:NVAX) journey from micro-cap to mid-cap has been nothing short of breath taking. The vaccine specialist has two potential blockbuster drugs in its pipeline: one for influenza and another for COVID-19. Back in March, the company reported positive phase 3 data from its flu shot candidate, Nano-Flu, and it is currently undergoing pivotal trials of its COVID-19 candidate with data expected in the first quarter of 2021.

  1. Vaxart

Vaxart’s (NASDAQ:VXRT) also went from micro-cap to small-cap in 2020 due to its own development of a COVID-19 vaccine candidate. But while Novavax counted on $1.6 billion from Operation Warp Speed, Vaxart did not pull in any federal funding and had to issue stock to fund its phase 1 trial. Despite its slow progress, potential is immense as unlike all the major vaccine candidates, Vaxart’s COVID-19 vaccine is a pill, not a shot. Any piece of good news can further propel this stock to space.

  1. Cardiff Oncology

Cardiff Oncology (NASDAQ:CRDF) had a minuscule $10.6 million market cap at the beginning of the year but to almost $700 million. Its cancer drug that it licensed for $2 million from a private company is its future billion-dollar opportunity but its lead drug candidate, Onvansertib, is reportedly achieving success in fighting colon tumour while simultaneously being tested for prostate cancer and leukemia in phase 2 trials. Pivotal trials have not been reached yet but the early data was enough to lure in investors.

  1. Co-Diagnostics

Co-Diagnostics (NASDAQ:CODX) ran up from a $15 million valuation to $300 million when it provided an early diagnostic test for COVID-19. Co-Diagnostics already has products on the market and is highly profitable. Early sales of its diagnostics have caused revenue to jump to $47 million in the first three quarters of the year, its sales growth soared over 50,000% in the third quarter, and it boasts a 63% profit margin.

  1. Trillium Therapeutics

Trillium Therapeutics (NASDAQ:TRIL) saw its market cap skyrocket from $29 million to $1.2 billion this year. The biotech company specializes in drugs that shut down the CD47 protein in cancer cells, which instructs the immune system to leave the cancer cells alone. When this protein is shut down, the immune system can kill the cancer cells. While Trillium’s drugs are only in phase 1 trials, early data is beyond promising.

  1. Arcturus Therapeutics

mRNA vaccine developers Pfizer (NYSE: PFE), Moderna (NASDAQ:MRNA) and BioNTech (NASDAQ:BNTX) made headlines this year as their COVID-19 vaccines proved to be safe and effective. Arcturus Therapeutics (NASDAQ:ARCT) is another such specialist but it is lagging behind due to a lack of funds. Arcturus has vaccine candidates for COVID-19 and the flu, along with a variety of other mRNA drugs in clinical trials, including a possible treatment for cystic fibrosis. Still, it did go up 940% as the world is excited about this new technology.

  1. Celldex Therapeutics

Celldex (NASDAQ:CLDX) shares sold for $2 in January and now, they are standing at approximately $19 as the company got its drugs into clinical trails. The biotech has two cancer drugs in phase 1 trials, and another phase 1 drug for an inflammatory disease that causes hives.

  1. Retractable Technologies

Retractable Technologies (NYSEMKT:RVP) makes syringes with automatic retractable needles which became of vital importance during the pandemic because an accidental needle stick can infect medical workers with a patient’s disease. Retractable saw huge revenue gains this year as the government stockpiled syringes for upcoming vaccination.

  1. Moderna

Moderna had a $6 billion market cap already at the beginning of the year when it did not have any existing drug on the market. But COVID-19 allowed the company to show what it’s got and Moerna delivered by producing a vaccine with 94.1% efficacy. Now Moderna’s market cap is $61 billion with rest of its pipeline that has been validated with mRNA evidence.

  1. Seres Therapeutics

Seres Therapeutics (NASDAQ:MCRB) specializes in the genetic material of all the microscopic bacteria that exist in the gastrointestinal tract and seeks the beneficial gut bacteria. It has even joined forces with Nestle (OTC: NSRGY) on a drug in phase 3 trials for a type of colitis that affects half a million Americans every year, and a phase 2 drug for ulcerative colitis.

An even brighter outlook

Novavax, the best stock in 2020 will continue to soar if its phase 3 trials data is positive. Trillium and Seres have exciting drug platforms that are approaching deadly diseases in an entirely new way. 2020 has been a rough year for most, but investors in these 10 stocks sure had a silver lining and their future could be just as bright if they deliver on the promise.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

BenzingaEditorial

This Week’s Recap

Published

on

The market and the economy continue to open, which is probably a result of bottled-up demand for many products and services affected by the pandemic. Maybe the inflation or rising bond yields will trigger the selloff on the market at some moment, but the current Fed’s transitory inflation message has been accepted by many investors. Also, the best way to deal with inflation is to stay with your investments and keep your faith in the market. So, despite the jump of May’s consumer-price index, that did not affect the investors who adopted a different mindset, so all three major averages finished in a positive zone.

The Dow Jones Industrial Average managed to recover from one of the steeper declines, thanks to gains from companies like IBM (NYSE: IBM), Microsoft (NASDAQ: MSFT), and Salesforce (NYSE: CRM). The Nasdaq Composite Index has also risen 49.09 points to 14,069.42. The tech-heavy index continued with the positive run, led by DocuSign (NASDAQ: DOCU), Zoom Video (NASDAQ: ZM), and CrowdStrike (NASDAQ: CRWD).

Tuesday brought us an earnings report from Oracle

Although it was a slim week for the earnings reports, Oracle (NYSE: ORCL) announced its last quarter results, as well as plans and guidance. The results are better than expected, as the achieved revenues were $11.23 billion (compared to the expected $11.04 billion) and the achieved adjusted earnings of $1.54 per share (compared to the expected $1.31). On the other hand, the company revealed its quarterly revenue guidance, which is lower than expected due to the plans to increase investments to support its cloud strategy and keep migrating existing on-premises customers to the cloud. This all led to a share fall of 5%, as many investors are skeptical if Oracle can successfully compete with major “cloud” players like Amazon (NASDAQ: AMZN), Salesforce, or Workday (NASDAQ: WDAY).

Adobe reported impressive results on Thursday

The Wall Street analysts recognized the work-from-home trend and this second digitization era as the main reasons for Adobe’s (NASDAQ: ADBE) sustained growth and therefore a monster quarter. And they were right. The company reported revenues of $3.84 billion, which is an increase of 23% compared year to year. That is also above the Wall Street estimate of $3.73 billion. The digital media business revenues, consisting of Creative Cloud and Document Cloud, grew by 25% compared to the previous year. The adjusted earnings per share were $3.03, which is higher than the estimated $2.81. For the following quarter, the company expects revenues of $3.88 billion and adjusted earnings per share of $3.00.

Conclusion

All these factors taken together, proven by positive index movements and earnings results better than anticipated, support the fact that the economic recovery is firmly underway, and those are very encouraging news.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

Continue Reading

BenzingaEditorial

Several new earnings reports and more management presentations this week

Published

on

We might be witnessing the lower volume of quarterly earnings reports this week, but that only means we passed last quarter’s report peak and we are getting ready for the June-quarter earnings season, which will hit us not long after the 4th of July. However, we do not lack many management presentations, which are typical after announcing earnings reports. This week brings us news for future result expectations from more than 30 companies, so let’s try and not miss any important clues. Besides earnings reports, this week is bringing us a total of 9 new IPOs like Marqeta, Inc. (NASDAQ: MQ), TaskUs, Inc. (NASDAQ: TASK), LifeStance Health Group, Inc. (NASDAQ: LFST), monday.com Ltd. (NASDAQ: MNDY), Zeta Global Holdings Corp.(NYSE: ZETA) and Jaws Hurricane Acquisition Corp (NASDAQ: HCNEU).

Monday

Yesterday we saw the first quarter report of fiscal 2022 for Marvell Technology (NASDAQ: MRVL), a Delaware-based company that develops and produces semiconductors and related technology. Marvel Technologies reported new revenues of $832 million, which is an increase of 20% year-to-year. GAAP gross profit margin was 50.2% and non-GAAP gross margin was 64.3%, while GAAP diluted loss per share was $0.13 and non-GAAP diluted income per share was $0.29.

Also, Vail Resorts, Inc. (NYSE: MTN) which owns and operates several premier mountain resorts in Colorado and California, reported fiscal 2021 third-quarter results yesterday. The report showed a net income of $274.6 million which is an increase of 80% compared to the third fiscal quarter of 2020. The reported EBITDA was $462.2 million, which is a significant increase from last year same quarter’s $304.4 million.

Tuesday

Besides earnings reports from Navistar International (NYSE: NAV) and Calavo Growers (NASDAQ: CVGW) on Tuesday, we are also expecting reports from Thor Industries (NYSE: THO), Casey’s General Stores (NASDAQ: CASY), and ABM Industries (NYSE: ABM).

Wednesday

Wednesday is reserved for earnings reports from Brown Forman (NYSE: BF-B), United Natural Foods (NYSE: UNFI), and Restoration Hardware (NYSE: RH). RH, the California-based furnishing company is expected to report earnings of $3.99 per share, which is growth of over 214% compared to the same period last year. Also, GameStop Corp (NYSE: GME), one of the world’s largest video game retailer’s earnings report is expected on Wednesday. The expected loss for the first quarter is $0.68 per share, which is an improvement from the same period last year (-%1.61 per share). In order to accelerate its transformation, the company decided to restructure its board, so it can keep up with industry growth and company expansion in the digital arena.

Thursday

On Thursday, we expect to see reports from National Beverage (NASDAQ: FIZZ), Chewy (NYSE: CHWY), and Dave & Buster’s (NASDAQ: PLAY). Chewy, the Florida-based pet store retailer, is expected to report a quarterly revenue growth of over 125%, compared year over year.

Friday

We are not expecting any major earnings reports on Friday.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

Continue Reading

BenzingaEditorial

The week may be starting slowly but do not let that mislead you

Published

on

The celebration of Memorial Day in the U.S. caused the slower start, but the rest of the week will bring us plenty of news, updates, and earnings reports from companies like Zoom Video Communications (NASDAQ: ZM), Hewlett-Packard Enterprise (NYSE: HPE), Advanced Auto Parts (NYSE: AAP) and Slack Technologies, Inc. (NYSE: WORK). This week will also bring us news from the EV and the IPO worlds, as well as the 2021 Bitcoin conference, one of the biggest cryptocurrency events this year. Before we move to the day-to-day highlights, if you are a small business owner, do not miss today’s deadline to apply for the latest round of the Paycheck Protection Program funding.

Tuesday

This week’s earnings reports will be led by Kirkland’s Inc (NASDAQ: KIRK), and that is due before the market opens. It will be followed by HP’s and Zoom’s earnings reports, after the bell. SoFi Technologies (NYSE: SOFI) is a fintech startup IPO joining the trading world after its SPAC merger on Friday.

 

Wednesday

Before the market opens on Wednesday, we are expecting the earnings reports from Advance Auto Parts and Lands’ End Inc (NASDAQ: LE). The reports will keep coming after the bell as well, so we are keen to see how NetApp Inc (NASDAQ: NTAP), Endeavor Group Holdings (NYSE: EDR), Splunk Inc (NASDAQ: SPLK), and PVH Corp (NYSE: PVH) did in the previous period. Wednesday is also the day when we are expecting the Beige Book, which will give us the latest analysis of the economic conditions in the U.S. as the COVID-19 restrictions reduce.

Thursday

Thursday is expected to be the busiest of the week, when we expect earnings reports from Express Inc (NYSE: EXPR), Asana Inc (NYSE: ASAN), Duluth Holdings Inc (NASDAQ: DLTH), Broadcom Inc (NASDAQ: AVGO), The Toro Company (NYSE: TTC), The Cooper Companies (NYSE: COO), Science Applications International Corporation (NYSE: SAIC), Lululemon Athletica (NASDAQ: LULU), as well as Slack Technologies.

Thursday is a big day for NVIDIA Corporation (NASDAQ: NVDA) also. After reporting the record profits and earnings, highly affected by the company’s revenues from graphic cards for crypto mining, the shareholders will vote on a 4-for-1 stock split. That will increase the number of authorized shares of common stock, and if approved, each shareholder will receive an additional dividend of three additional shares.

Thursday will be also interesting in the automotive world. Kia will start taking reservations for its new EV6 crossover, while Nio Inc (NYSE: NIO), the Chinese automaker, will hold a general meeting so it can increase the diversity of its board.

This day will also be dominated by cryptocurrencies, as the 2021 Bitcoin conference, taking place in Miami, will kick-off.

Friday

The week’s end is reserved for the earnings report from Hooker Furniture Corporation (NASDAQ: HOFT), and that is expected before the opening bell. During the rest of Friday, we will focus on the latest unemployment rates and data.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

Continue Reading
Advertisement

TRENDING

Advertisement

Submit an Article

Send us your details and the subject of your article and an IAM editor will be in touch with you shortly

Trending